General MedicationsORALStandard

KETOPROFEN

Standard Dose

25MG

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview KETOPROFEN is listed in Drugs@FDA under application 074014 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient KETOPROFEN Form and strength CAPSULE;ORAL - 25MG Sponsor MISEMER Submission history Latest submission status date: 2024-11-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview KETOPROFEN is listed in Drugs@FDA under application 074014 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient KETOPROFEN Form and strength CAPSULE;ORAL - 25MG Sponsor MISEMER Submission history Latest submission status date: 2024-11-22 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.